Glaxo Group Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Glaxo Group Limited

Patent Number:
Title:
Dispensing Device
Applicant:
Opposition Date:
Dec 2, 2021
Patent Number:
Title:
Method Of Obtaining Thermostable Dried Vaccine Formulations
Opposition Date:
Feb 5, 2021
Patent Number:
Title:
Method Of Making Particles For Use In A Pharmaceutical Composition
Applicant:
Opposition Date:
May 6, 2020
Patent Number:
Title:
Pharmaceutical Compositions For Inhalation
Applicant:
Opposition Date:
Aug 12, 2019
Patent Number:
Title:
Dispensing Device
Applicant:
Opposition Date:
Jul 19, 2019
Patent Number:
Title:
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
Opposition Date:
Dec 18, 2018
Patent Number:
Title:
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
Opposition Date:
Dec 18, 2018
Patent Number:
Title:
Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In Bioreactors
Applicant:
Opposition Date:
Sep 20, 2018
Patent Number:
Title:
Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides
Applicant:
Opposition Date:
Aug 27, 2018
Patent Number:
Title:
Method Of Making Particles For Use In A Pharmaceutical Composition
Applicant:
Opposition Date:
May 1, 2018

Latest patents of Glaxo Group Limited opposed by its competitors

Patent:
Grant Date:
Jun 26, 2024
Title:
Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol
Oppositions:
1
Patent:
Grant Date:
Sep 7, 2022
Title:
Medicament Dispenser
Oppositions:
1
Patent:
Grant Date:
May 18, 2022
Title:
Counter For Use With A Medicament Dispenser
Oppositions:
1
Patent:
Grant Date:
Mar 18, 2020
Title:
Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom
Oppositions:
1
Patent:
Grant Date:
May 22, 2019
Title:
Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)Phenol
Oppositions:
8
Patent:
Grant Date:
Dec 20, 2017
Title:
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist
Oppositions:
3
Patent:
Grant Date:
Oct 11, 2017
Title:
Hbv Antisense Inhibitors
Oppositions:
1

Want to track Glaxo Group Limited?

Feel free to send us a message here and we will get back to you